A number of other research analysts also recently issued reports on the company. Zacks Investment Research upgraded Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Monday, July 8th. ValuEngine upgraded Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Monday, April 1st. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $41.25.
CENTA opened at $25.76 on Friday. The business’s fifty day moving average price is $25.65. The stock has a market cap of $1.44 billion, a P/E ratio of 13.49, a P/E/G ratio of 3.40 and a beta of 0.03. Central Garden & Pet has a 52 week low of $23.07 and a 52 week high of $40.99. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.52 and a quick ratio of 2.79.
Central Garden & Pet (NASDAQ:CENTA) last released its quarterly earnings data on Monday, May 6th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.67 by $0.05. The company had revenue of $673.70 million for the quarter, compared to the consensus estimate of $645.58 million. Central Garden & Pet had a return on equity of 9.92% and a net margin of 4.19%. Equities analysts anticipate that Central Garden & Pet will post 1.81 EPS for the current year.
Large investors have recently made changes to their positions in the company. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Central Garden & Pet in the 1st quarter valued at $56,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Central Garden & Pet by 30.4% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,454 shares of the company’s stock worth $80,000 after buying an additional 805 shares during the last quarter. QS Investors LLC grew its stake in Central Garden & Pet by 314.3% during the 4th quarter. QS Investors LLC now owns 5,800 shares of the company’s stock worth $182,000 after buying an additional 4,400 shares during the last quarter. NumerixS Investment Technologies Inc purchased a new position in Central Garden & Pet during the 1st quarter worth $142,000. Finally, SG Americas Securities LLC purchased a new position in Central Garden & Pet during the 1st quarter worth $185,000. Institutional investors and hedge funds own 66.52% of the company’s stock.
About Central Garden & Pet
Central Garden & Pet Company, together with its subsidiaries, produces and distributes products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments, Pet and Garden. The Pet segment supplies products for dogs and cats, including edible bones, edible and non-edible chews, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and products for birds, small animals, and specialty pets, such as food, cages and habitats, toys, chews, and related accessories.
Recommended Story: What is the S&P 500 Index?
Receive News & Ratings for Central Garden & Pet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Garden & Pet and related companies with MarketBeat.com's FREE daily email newsletter.